Coronavirus
Investors seek drugmakers in rush to treat coronavirus
Generic antivirals may help while medics scramble to develop vaccine
Biotechnology
Companies
Celltrion plans $500m factory in Wuhan to tap China drug market
Korean biotech company eyes local talent in first overseas production move
Technology
Toshiba taps quantum cryptography to send genome data
Hacker-proof technology to be used in finance
Society
Chinese 'gene-editing' scientist sentenced to three years in prison
Team altered babies' genes, attempting to protect them against AIDS virus
Business deals
Amgen buys $2.7bn in BeiGene to sell cancer drugs in China
US biotech company to own one-fifth of Chinese counterpart in all-cash deal
Pharmaceuticals
South Korea's biotech ambitions overshadowed by scandals
Clinical failures and fraud allegations overshadow industry touted as next frontier
Pharmaceuticals
Biogen and Japanese partner Eisai resurrect Alzheimer's drug
Shares of US company gain 27%, make up ground lost after trial's abandonment
Business deals
Singapore-based VC nears first close of $500m tech fund
Vickers Venture Partners plans to invest in biotechnology and artificial intelligence
Biotechnology
Fujifilm's Komori says health care can double to $10bn business
CEO sees M&A boosting scale while mainstay copier operations slow down
